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Background: Calcium carbonate is a common urolith type in small ruminants with no high-yield
experimental model to evaluate animal susceptibility or preventative measure response.
Hypothesis: That novel plastic winged implants would allow accumulation and quantification of
calcium carbonate calculus formation in goats on a high-calcium diet and identify individual varia-
tion between goats in the mass of calculi produced.
Animals: Eight nonpregnant 3- and 4-year-old Boer-cross does, weighing 22.3–39.5 kg, deter-
mined to be healthy based on physical examination, were used in these experiments.
Methods: Prospective cohort study for in vivo experimental model development. Implants were
placed into the urinary bladder lumen in 8 goats over 2 evaluation periods. The alfalfa-based ration
had a total ration Ca : P of 3.29 and 3.84 : 1, respectively. Urine was collected at 0, 28, 56, and 84
days in the 1st experiment; blood and urine at those timepoints in the 2nd experiment. For each
evaluation period, the implants were removed 84 days after implantation and weighed. Accumu-
lated calculi mass was calculated and compared between goats and was analyzed for composition.
Results: Implant retention was 100% and 86% in the 2 studies. All goats with retained implants
accumulated calcium carbonate at a mean implant gain per day across studies ranging from 0.44 to
57.45 mg. Two goats accumulated (0.44–7.65 mg/day and 33.64 & 57.45 mg/day) significantly
more urolith material than the cohort across both studies (P5 .047). No routine analytes on blood
or urine were found to be explanatory for the difference observed.
Conclusions and Clinical Importance: These findings form a basis for implant and diet selection
for use in future studies of urolithiasis development and for studies regarding individual suscepti-
bility to urolithiasis.
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1 | INTRODUCTION
Small ruminant urolithiasis affects all types of small ruminant enter-
prises, including commercial production, exhibition, and pet keeping. It
negatively influences welfare and longevity and causes important eco-
nomic losses. Challenges in treating urolithiasis in ruminants require that
prevention be the focus of disease management. Struvite,1–3 calcium
carbonate,1,2,4–7 calcium phosphate (apatite),2,8 and amorphous magne-
sium calcium phosphate (AMCP)5,7 are cited as common urolith types in
small ruminants and therefore serve as the focus of most research
efforts. Shared characteristics of these urolith types are formation in
supersaturated and alkaline urine and, as such, studies have focused on
diluting and acidifying urine through dietary modification.9–12 These
projects have not evaluated these interventions on the formation or dis-
solution of uroliths or urolith components. Further, these preventative
measures have generally been directed at these nonspecific, shared
characteristics, rather than toward a specific urolith type. This is prob-
lematic because preventative measures for 1 urolith type could actually
predispose to another. For example, urine acidification using anionic
salts aimed at preventing phosphatic urolith types can predispose to
calcium-containing uroliths by increasing urinary excretion of calcium.4,9
There is a need to evaluate preventative measures in light of uro-
lith formation rather than simply urine biochemical characteristics, and
to develop preventative strategies for specific urolith types. Experimen-
tal models of this sporadic disease provide an opportunity to obtain
sufficient power for such studies while minimizing animal use. An
experimental model of AMCP urolithiasis has been developed in female
goats, using zinc washers as a nidus for urolith formation.13 The model
was successful in inducing urolith formation in all goats, but there were
problems with implant retention, with 25%-50% of animals losing their
implants across 4 studies.13
Recent studies have shown calcium carbonate to be the most
common urolith type in some settings,6,7 particularly in small rumi-
nants identified as pets.7 The development of a predictable and con-
sistent model of calcium carbonate urolithiasis in goats is a critical
need in the study of dietary causes and management of this disease.
The 1st objective of these studies was to develop or identify a novel
implant design with a high (>75%) rate of retention in the urinary
bladder and ability to serve as a nidus for urolith accumulation. The
2nd objective was to determine if an alfalfa-based ration with an
increased Ca : P ratio would induce calcium carbonate urolith forma-
tion on that intraluminal urinary bladder implant. The additional
objective of Experiment 2 was to determine if there was individual
variation in urolith mass accumulation among goats on a high Ca : P
diet. Our hypotheses were that novel plastic winged implants would
be retained at a rate greater than 75%, accumulate calcium carbon-
ate uroliths on the high-calcium diet, and that individual variation
exists between goats in urolith mass produced.
2 | MATERIALS AND METHODS
Procedures used in this study were approved by the Institutional Ani-
mal Care and Use Committee at Texas A&M University.
2.1 | Animals and housing
Eight nonpregnant 3- and 4-year-old Boer-cross does, determined to
be healthy based on physical examination, were used in these experi-
ments. Initial body weights ranged from 22.3 to 39.5 kg. In Experiment
1, goats were group housed in 3 indoor stalls (3 goats in each of 2
stalls, 2 goats in the remaining stall) with wood shaving bedding. In
Experiment 2, goats were individually housed in indoor stalls with
wood shaving bedding.
2.2 | Feed
The diet for both studies consisted of chopped alfalfa hay and a pelleted
ration. The pelleted ration base was corn, soybean hulls, wheat midds,
alfalfa, soybean meal, rice bran, and included ammonium chloride. A par-
tial dietary analysis including parameters of interest is shown in Table 1.
In Experiment 1, the total diet was fed at a rate of 4% of body weight,
1 : 1 alfalfa : pellets by weight in a group-fed situation. In Experiment 2,
the total diet was fed at a rate of 3% of body weight, 1 : 1
alfalfa : pellets by weight and each goat was fed individually. No addi-
tional forage or mineral sources were available during the experimental
periods and municipal water was available ad libitum. Goats were accli-
mated to the diet in each experiment over the course of 14 days before
the start of the study. The studies were performed 5.5 months apart.
2.3 | Implants
For Experiment 1, intrauterine contraceptive devices (Paragard,
Duramed Pharmaceutical, Inc, Pomona, New York, 10970) designed for
human use measuring 32 mm 3 35 mm were prepared by removal of
the copper wire wrap on the shaft and replacement with a 30-throw
Chinese finger trap suture pattern using #1 catgut (Catgut Chrom, B
Braun Aesculap, Center Valley, Pennsylvania, 18034). For Experiment
2, T-shaped devices were printed in plastic (Ninjaflex Semiflex,
Ninjatek, Manheim, Pennsylvania, 17545) measuring 36 mm 3 37 mm,
TABLE 1 Selected variables from dietary analysis of the total ration
used in each experiment
Analyte Experiment 1 diet Experiment 2 diet
Net energy maintenance 0.29 Mcal/lb 0.30 Mcal/lb
Crude protein 17.25% 14.80%
Phosphorus 0.42% 0.37%
Calcium 1.38% 1.42%
Ca : P 3.29 : 1 3.84 : 1
Potassium 1.67% 2.09%
Magnesium 0.29% 0.32%
Sulfur 0.22% 0.21%
Sodium 0.21% 0.26%
Chloride 0.95% 1.23%
Dietary Cation Anion
Difference (DCAD) (calc.)
113.69 mEq/kg 154.88 mEq/kg
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with #1 catgut (Catgut Chrom, B Braun Aesculap, Center Valley, Pennsyl-
vania, 18034) suture placed in a 30-throw Chinese finger trap suture pat-
tern on the shaft (Figure 1). In both experiments, the prepared implants
were weighed and stored in isopropyl alcohol before implantation.
2.4 | Implant procedure and maintenance
Before scheduled implant placement, feed was withheld for 12 hours
with water available at all times. Xylazine (0.1 mg/kg, intravenous) was
administered to the goats and anesthesia was induced with 3% sevo-
flurane in oxygen via facemask. Goats were maintained at a surgical
plane of anesthesia using sevoflurane via facemask. Each animal was
placed in sternal recumbency with hip extension. The vulva was
cleaned with 2% chlorhexidine scrub and 99% isopropyl alcohol. The
operator inserted a lubricated, gloved index finger into the vulva and
identified the external urethral orifice. The implant was loaded into an
insertion device, introduced into the urethra, and deployed into the
bladder using a plunger. The insertion device for Experiment 1 was a
20 French red rubber catheter with the closed end removed and a
4 cm lengthwise slit created. In Experiment 2, the insertion device was
rubber tubing with an outside diameter of 8 mm, inside diameter of
4 mm, and measuring 19.5 cm in length with a 4 cm lengthwise slit. For
both, the plunger from the contraceptive kit was used to deploy the
implant from the insertion device. Proper placement of the implant was
confirmed by transurethral visualization using a 5 mm 3 55 cm flexible
endoscope. Goats were recovered from anesthesia and returned to
their home pen and continued on the study diet. After implantation,
goats were monitored at least twice daily for attitude, appetite, and
any changes in micturition.
Goats underwent transurethral endoscopy of the urinary bladder
every 4 weeks to determine the presence and appearance of the
implant and assess urinary bladder health. Implants were removed after
endoscopic visualization 84 days after placement using 5 mm 3 43 cm
laparoscopic atraumatic grasping forceps used in tandem with the
endoscope, weighed, and stored in vials until analysis.
2.5 | Blood and urine analysis
During the group-fed study, urine was collected via the endoscope on
days 0, 28, 56, and 84. During the individually fed study, urine collec-
tion and analysis were performed as for the group-fed study and blood
was collected from the jugular vein at the same timepoints.
Urinalysis included dipstick examination (Multistix 10 SG, Siemens
Healthcare Diagnostic, Inc, Tarrytown, New York, 10591), urine specific
gravity via refractometer, and urine pH using a benchtop pH meter.
Packed cell volume and total plasma protein were determined in blood
and biochemistry analysis was performed including pH, total and ion-
ized calcium, blood urea nitrogen, creatinine, and bicarbonate.
2.6 | Urolith analysis
After removal, the implant and associated urolith material was submit-
ted to the G.V. Ling Urinary Stone Analysis Laboratory in Davis, Califor-
nia, where uroliths were screened using optical crystallography,
followed by infrared spectroscopic confirmation of composition.
2.7 | Statistical analysis
Urolith accumulation was calculated by subtraction of the weight of
each implant before implantation from the weight after implantation.
Urolith mass accumulated per day was calculated for each implant
and the mean determined for each goat across studies. One-way
analysis of variance analysis was used to determine if there was a dif-
ference in the mean implant gain per day by goat across both studies.
A 2 sample t test was then performed to determine if there was a dif-
ference in urolith accumulation between studies (group feeding ver-
sus individual feeding). Logistic regression was then used to compare
blood and urine analytes of high and low urolith formers for explana-
tory variables.
3 | RESULTS
3.1 | Experiment 1
All implants were retained in the urinary bladder of all 8 goats for the
duration of the study. All implants accumulated urolith material during
the study. Implant gain per day for all goats ranged from 0.44 mg to
47.20 mg (median55.16 mg). Two goats accumulated high amounts of
urolith material with an implant gain of 13.29–47.20 mg/day
(median530.25 mg/day). The remaining 6 goats accumulated smaller
amounts of urolith material, ranging from 0.44 to 7.40 mg/day
(median53.77 mg/day). Accumulated urolith material was analyzed to
be 100% calcium carbonate in all animals. Urine dipstick analysis
FIGURE 1 Printed implant from Experiment 2. A 30-throw
Chinese finger trap suture pattern of #1 catgut has been placed on
the vertical portion to enhance urolith adherence
JONES ET AL. Journal of Veterinary Internal Medicine | 3
revealed no notable abnormalities throughout the study. Mean urine
pH throughout the study was 8.15 and mean urine specific gravity was
1.022 (reference range: 1.015–1.045).
3.2 | Experiment 2
Six goats completed Experiment 2 with the implant retained in the uri-
nary bladder. One goat from Experiment 1 was excluded from Experi-
ment 2 due to problems with implant placement and 1 additional goat
had lost the implant by the time of endoscopy performed 4 weeks after
implantation (retention rate: 86%). All retained implants accumulated
urolith material during the study (Figure 2). Implant gain per day for all
goats ranged from 2.64 mg to 67.71 mg (median59.22 mg). Two goats
accumulated high amounts of urolith material with an implant gain of
53.98–67.71 mg/day (median560.85 mg/day). The remaining 4 goats
accumulated smaller amounts of urolith material, ranging from 2.64 to
9.22 mg/day (median56.88 mg/day). Accumulated urolith material
was analyzed to be 100% calcium carbonate in 5 animals, while urolith
material for the remaining goat was 90%-95% calcium carbonate and
5%-10% struvite. Urine dipstick analysis revealed no notable abnormal-
ities throughout the study. Mean urine pH throughout the study was
8.06 and mean urine specific gravity was 1.019 (reference range:
1.015-1.045). All blood analytes were within reference ranges through-
out the study for all goats.
There was no significant difference between the 2 studies (group
versus individual feeding) in implant weight gain per day (P5 .25).
Mean implant weight per day for each goat across both studies
was calculated. Mean implant gain per day was significantly different
between goats, with 2 goats producing more urolith material than the
remaining 4 (P5 .047). The high urolith accumulation goats (n52) had
an implant gain of 33.64–57.45 mg/day (median545.55 mg/day),
while the low urolith accumulation goats had an implant gain of
0.44–7.65 mg/day (median54.70 mg/day).
Logistic regression comparison of groups (large mass formers ver-
sus small mass formers) found no explanatory variables from blood or
urine analysis to be significantly different.
4 | DISCUSSION
Plastic winged implants used in this study were retained in greater than
75% of implanted goats. Goats consuming an alfalfa-based ration pro-
duced calcium carbonate urolith material and there were statistically
significant differences between goats in urolith mass accumulated.
The 1st objective of the study was to determine if a novel winged
implant would be retained in the urinary bladder of does for the dura-
tion of the study in greater than 75% of animals. Four previous experi-
ments using zinc washers in goats achieved only 50%–75% retention
rates for the duration of the studies.13 The winged design of the
implants in this current study appear to be an improvement on this
model, with retention rates of 100% and 85.7%. Intrauterine devices
designed for human use are not accessible to veterinary researchers
due to a median device cost of $778,14 so the 3D printed implant was
designed. It can be printed for less than $0.25 USD in materials cost
and appears to have the proper flexibility and rigidity to be retained,
and tolerance for the environment of the urinary bladder, for sufficient
FIGURE 2 Printed implants from the 6 goats completing Experiment 2, goats B, C, E, F, G, H. Note the urolith mass accumulated by goats
B and H, which was significantly greater than the other goats (P5 .047)
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time to carry out experiments. The implant of Goat B, as seen in Figure
2, demonstrates the tensile strength of the material when urolith accu-
mulation is excessive. It is clear that, in animals who are high urolith
accumulators, the catgut suture modification may not be necessary, as
urolith accumulation occurred on bare portions of the implant. In future
studies where dietary interventions can be studied using animals along
the spectrum of urolith accumulation potential, this suture modification
appears to facilitate urolith component adhesion.
The experimental diet of a pelleted ration and chopped alfalfa,
group-fed at 4% of body weight and individually fed at 3% of body
weight, induced calcium carbonate urolithiasis in all goats. This confirms
traditional ideas that legume-based rations predispose to calcium car-
bonate urolithiasis. It also raises concerns about general recommenda-
tions to feed high-calcium feeds based on the evidence suggesting that
Ca : P ratios of rations above 2 : 1 prevent urolithiasis.15,16 This recom-
mendation can prevent phosphatic calculi such as struvite, but is likely
to increase the risk of calcium-based uroliths. In addition, the common
inclusion of ammonium chloride in these diets induces an acidemia, not
demonstrated in this study, further increasing calcium excretion into the
urine,4,9 making it available for incorporation into the urolith matrix.
For various urolith types, a genetic predisposition to being a “stone
former” has been suggested or confirmed in humans,17 dogs,18 and
cats.19 In small ruminants, individual susceptibility has been discussed
but not documented. Often, there is a superimposition of risk factors.
For example, it may be the impression of a clinician that Pygmy goats
are predisposed to obstructive urolithiasis. However, Pygmy goats are
more often kept as pets, an animal use type which is at increased odds
of developing calcium carbonate urolithiasis,7 although the mechanism
for this is undetermined. At the end of Experiment 1, the differences in
urolith mass formation of goats B and H became clear and we devel-
oped 2 hypotheses regarding this. First, there could be inherent charac-
teristics, perhaps genetic or metabolic, which result in some individuals
producing significantly more urolith mass than other animals on the
same diet (P5 .047). Second, given that animals were group-fed in the
1st experiment, these animals could have simply consumed more feed,
making more mineral available for incorporation onto the implant.
Experiment 2 controlled for possible differences in dry matter intake
and we were therefore able to demonstrate that individuals of the
same breed makeup as their cohort, when fed a diet identical to the
cohort, including dry matter intake, developed significantly more urolith
mass than the remainder of the cohort. This finding raises questions
regarding the expected long-term outcomes for animals that have pre-
sented for calcium carbonate urolith obstruction.
We were unable to demonstrate a possible mechanism for the
excess urolith formation by these 2 individuals by routine blood and
urine analyses. In a case series of cats with calcium-containing uroliths
(calcium oxalate), all had increased ionized and total calcium levels,20
which was not seen in the individuals in our studies. Additional studies
comparing the composition of the urine of stone formers to the general
population of goats and other metabolic studies will need to be per-
formed to elucidate the basis for the difference noted in these studies.
A defined mechanism could form the basis for screening of individuals,
particularly pets or breeding males, for predisposition to this disease.
In conclusion, a novel plastic winged implant was retained at a sat-
isfactory rate in the urinary bladder of goats and served as a nidus for
urolith accumulation. An alfalfa-based diet, including a commercial pel-
leted ration, resulted in calcium carbonate urolith formation in all goats
on the study diet and there was a statistically significant difference in
the mass of urolith accumulated across goats. These findings provide a
basis for implant and diet selection for use in future studies of urolithia-
sis development, as well as a basis for client education regarding diet
and management of individual goats in the clinical setting.
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